Immediate Impact

4 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
E-Tattoos: Toward Functional but Imperceptible Interfacing with Human Skin
2024 Standout
2 intermediate papers

Works of Michael Kurek being referenced

Association Screening in the Epidermal Differentiation Complex (EDC) Identifies an SPRR3 Repeat Number Variant as a Risk Factor for Eczema
2011

Author Peers

Author Last Decade Papers Cites
Michael Kurek 91 113 15 74 9 226
Debbie Crumrine 104 157 33 44 10 288
Pouya Sarvari 130 73 21 53 10 288
John L. Burton 40 81 25 29 10 227
Brent Meengs 158 33 15 21 10 266
Hélène Hernandez-Pigeon 107 96 7 38 10 256
Konstantinos Katsoulis‐Dimitriou 40 42 5 41 7 220
T. Piskáčková 28 53 16 42 6 150
Kaitlyn M. Eckert 179 34 51 15 11 285
Kristina L. Stone 77 30 41 12 8 207
André Mahns 73 136 29 8 9 282

All Works

Loading papers...

Rankless by CCL
2026